Indicatively, Empa decreased CV loss of life considerably, while Dapa and Cana didn’t. taken care of at week 52 (?0.74%, ?0.96%, and 0.01%, respectively) [42]. Furthermore, another RCT reported the fact that addition of Cana 100 or 300 mg in sufferers inadequately managed with metformin and pioglitazone, resulted in reduced HbA1c in comparison to placebo […]